Filgrastim-Treated Donor Peripheral Stem Cell Transplantation in Treating Patients With Acute Leukemia</p>
Leukemia

About this trial
This is an interventional treatment trial for Leukemia focused on measuring recurrent childhood acute lymphoblastic leukemia, recurrent childhood acute myeloid leukemia, recurrent adult acute myeloid leukemia, recurrent adult acute lymphoblastic leukemia, adult acute lymphoblastic leukemia in remission, childhood acute lymphoblastic leukemia in remission, acute undifferentiated leukemia, secondary acute myeloid leukemia
Eligibility Criteria
DISEASE CHARACTERISTICS: One of the following diagnoses: Primary acute leukemia beyond first remission High-risk acute myelogenous leukemia Acute lymphoblastic leukemia in first remission Must have HLA-matched donor identical for HLA-A, -B, and DRB1 alleles No HLA-matched identical sibling or haploidentical relative incompatible for 0 or 1 HLA-A, -B, or -DRB1 loci on the non-shared haplotype No leukoencephalopathy PATIENT CHARACTERISTICS: Age: 55 and under Performance status: Not specified Life expectancy: Not specified Hematopoietic: Not specified Hepatic: SGOT no greater than 2 times normal Hepatitis B surface antigen negative No prior hepatitis C Renal: No impaired renal function Creatinine less than 2 times normal Cardiovascular: No symptomatic cardiac disease Pulmonary: No active pulmonary disease DLCO at least 60% predicted Other: HIV negative No disease or other malignancy that severely limits life expectancy No severe or life-threatening infection within the past 2 weeks No history of septate fungal infection or disseminated candidiasis PRIOR CONCURRENT THERAPY: Biologic therapy: No prior bone marrow or peripheral blood stem cell transplantation Chemotherapy: Not specified Endocrine therapy: Not specified Radiotherapy: No prior radiotherapy greater than 3,000 cGy to whole brain No prior radiotherapy of 1,500 cGy to chest or abdomen At least 6 months since prior involved-field radiotherapy to chest or abdomen Surgery: Not specified
Sites / Locations
- Fred Hutchinson Cancer Research Center